Effect of Primidone on Platelet Responsiveness in Patients Determined to be Clopidogrel Resistant
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether adding primidone will improve the
metabolism of clopidogrel thereby increasing metabolite levels within the blood stream and
platelet response to clopidogrel in patients who were previously found to lack adequate
response to clopidogrel. This information could help overcome clopidogrel resistance in
patients who are at risk for stroke or transient ischemic attack (TIA).